7Wang HL, Ning T, Li M, et al. Effect of endostatin on preventing postoperative progression of distant metastasis in amurine lung cancer model. Tumori ,2011,97 : 787- 793.
8Li CY,Wang XL, Wang JH, et al. Identifying serum biomarkers for TACE therapy efficiency ofhepatocellular carcinoma. Front Biosci ( Elite Ed ), 2011,3 : 212- 220.
9Lent EM, Crouse LC, Quinn MJ Jr, et al. Assessment of the in vivo genotoxicity of isomers of dinitrotoluene using the alkaline Comet and peripheral blood micronucleus assays. Mutat Res ,2012,742:54-60.
10Cardinale F,Bruzzi P,Bolognesi C. Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis. Br J Cancer, 2012, 106:780-790.
4Iwamoto H,Torimura T,Nakamura T, et al. MetronomicS-l chemotherapy and vandetanib:an efficacious and non-toxic treatment for hepatocellular carcinoma [J], Neopla-sia,2011,13(3) :187-197.
5Ghiringhelli F,Menard C,Puig PE,et al. Metronomic cy-clophosphamide regimen selectively depletes CD4 +CD25 + regulatory T cells and restores T and NK effectorfunctions in end stage cancer patients [J]. Cancer Immu-nol Immunother,2007,56(5) : 641-648.
